The outbound investment by the Chinese companies has been on the increase for 15 consecutive years, which hit its historical record in 2016 at US$190 billion. China is undoubtedly becoming one of the major “global purchaser〞who has 11% shares in Total Global Outward FDI Flows in 2016. The pace of outbound investment has been slow [...]
January 11, 2018 On December 26, 2017, the National Development and Reform Commission ("NDRC") formally issued the Measures for the Management of Overseas Investments in Enterprises. The new regulation is more market-oriented and the process is simplified. We can expect this new regulation to come into effect on March 1, 2018. Here are several major [...]
January 11, 2018 Chinese biotech firms are on track to raise about $10 billion in 2017, double the amount they raised in 2016, according to ChinaBio Consulting. The increase comes as China’s government initiated a series of regulatory changes in October 2017 to accelerate and streamline the approval of new drugs. Historically, most Chinese drug production has [...]
January 10, 2018 It is indeed positive news that the China’s Food and Drug Administration (CFDA) is now announcing removal of a requirement that Innovative Medical Devices—defined as new technologies not available in China—must have regulatory approval in their country of origin to qualify for registration. The change means that manufacturers of these devices will [...]
Annual Note from the Managing Partner. As calendar-year 2017 is coming to a close, Across Partners announces achievement of its major objectives. […]
In China's thirteen five plan, there are two major innovation industries that will become strategic focuses - robotics and biotechnology. According to the Ministry of Science and Technology development plan, by 2020, the ROBOTIC industry output is expected to exceed 100 billion yuan and BIOTECHNOLOGY will account for more than 4% GDP which marks it [...]
According to a PwC report released on 24th August, 2017, the number of Chinese outbound mergers and acquisitions hit a new high in the first half of 2017, demonstrating that demand for strategic overseas investments remains strong. While the total value of Chinese outbound merger and acquisition deals in the first half fell 13.3 percent [...]
Across Partners was this summer invited by the Danish-Chinese Business Forum to write their Article of the Month. The article talks about the inevitability of Chinese investment into Europe and the benefits of linking intercontinental economies. For a read copy this link into your browser: http://dcbf.dk/news/411-embrace-the-trend-of-chinese-investments-in-europe
August 7, 2017. Our client Lingen Precision Medical Products has entered into an exclusive Joint Venture with Nidacon International of Sweden. The Joint Venture will be based in Shanghai. Across Partners was instrumental in the whole process. Initially, we searched and identified Nidacon International as a qualified product supplier for Lingen’s future development in Assisted Reproduction Technology [...]
August 4, 2017 We now have a position open for a young intern. ACROSS PARTNERS is looking for a young aspiring analyst with China or M&A interest and experience. We specialize in attracting Chinese companies to invest a minority or majority in European companies. We make M&A and investment opportunities visible to Chinese investors, and [...]
